Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
It is well established that multifactorial drug resistance hinders successful cancer treatment.
Tumor cell interactions with the tumor microenvironment (TME) are crucial in epithelial …
Tumor cell interactions with the tumor microenvironment (TME) are crucial in epithelial …
Targeting the tumour stroma to improve cancer therapy
KC Valkenburg, AE De Groot, KJ Pienta - Nature reviews Clinical …, 2018 - nature.com
Cancers are not composed merely of cancer cells alone; instead, they are complex
'ecosystems' comprising many different cell types and noncellular factors. The tumour stroma …
'ecosystems' comprising many different cell types and noncellular factors. The tumour stroma …
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
SY Lee, EK Jeong, MK Ju, HM Jeon, MY Kim, CH Kim… - Molecular cancer, 2017 - Springer
Radiation therapy is one of the major tools of cancer treatment, and is widely used for a
variety of malignant tumours. Radiotherapy causes DNA damage directly by ionization or …
variety of malignant tumours. Radiotherapy causes DNA damage directly by ionization or …
Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment
L Bu, H Baba, N Yoshida, K Miyake, T Yasuda… - Oncogene, 2019 - nature.com
Increasing lines of evidence show that the malignant behavior of cancer is not exclusively
attributable to cancer cells but also radically influenced by cancerous stroma activity and …
attributable to cancer cells but also radically influenced by cancerous stroma activity and …
Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy
Y Yang, S Karakhanova, W Hartwig… - Journal of cellular …, 2016 - Wiley Online Library
Mitochondria are indispensable for energy metabolism, apoptosis regulation, and cell
signaling. Mitochondria in malignant cells differ structurally and functionally from those in …
signaling. Mitochondria in malignant cells differ structurally and functionally from those in …
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
Background Breast cancer (BC), the second most common cause of cancer-related deaths,
remains a significant threat to the health and wellness of women worldwide. The tumor …
remains a significant threat to the health and wellness of women worldwide. The tumor …
[HTML][HTML] Monocarboxylate transporters in the brain and in cancer
J Pérez-Escuredo, VF Van Hée, M Sboarina… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Monocarboxylate transporters (MCTs) constitute a family of 14 members among which
MCT1–4 facilitate the passive transport of monocarboxylates such as lactate, pyruvate and …
MCT1–4 facilitate the passive transport of monocarboxylates such as lactate, pyruvate and …
Caveolae as plasma membrane sensors, protectors and organizers
Caveolae are submicroscopic, plasma membrane pits that are abundant in many
mammalian cell types. The past few years have seen a quantum leap in our understanding …
mammalian cell types. The past few years have seen a quantum leap in our understanding …
Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
L Wilde, M Roche, M Domingo-Vidal, K Tanson… - Seminars in …, 2017 - Elsevier
abstract Glucose is a key metabolite used by cancer cells to generate ATP, maintain redox
state and create biomass. Glucose can be catabolized to lactate in the cytoplasm, which is …
state and create biomass. Glucose can be catabolized to lactate in the cytoplasm, which is …
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
MJ Bissell, WC Hines - Nature medicine, 2011 - nature.com
Tumors are like new organs and are made of multiple cell types and components. The tumor
competes with the normal microenvironment to overcome antitumorigenic pressures. Before …
competes with the normal microenvironment to overcome antitumorigenic pressures. Before …